Showing results (91-100 of 332) with videos related to
Sort By:
Pageof 34
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2021
Cumulative effects of therapies on disability in relapsing multiple sclerosisFabien Rollot, Romain Casey, Emmanuelle Leray, et al.Multiple Sclerosis and Related Disorders|February 5, 2026
Multiple sclerosis and uveitis: Clinical characteristics and prognosisWilliam Gil, Samuel Chacun, Géraldine Androdias, et al.Journal of the Neurological Sciences|January 9, 2020
Validation of a rapid and easy-to-perform screening test for neurocognitive impairment in HIV+ patientsHeloise Joly, Matteo Vassallo, Margaux Issaurat, et al.Annals of Clinical and Translational Neurology|August 8, 2025
Durable B-Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple SclerosisAlexandra Garcia, Stephane Rodriguez, Emilie Dugast, et al.Neurology(R) Neuroimmunology & Neuroinflammation|February 12, 2024
Impact of Immune Checkpoint Inhibitors on the Course of Multiple SclerosisGéraldine Androdias, Louise Noroy, Dimitri Psimaras, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2020
Clinical significance of a single cerebrospinal fluid immunoglobulin band: A retrospective studyMaud Tusseau, Estelle Cheli, Romain Marignier, et al.Annals of Clinical and Translational Neurology|April 8, 2021
Comparison of SimoaTM and EllaTM to assess serum neurofilament-light chain in multiple sclerosisAudrey Gauthier, Sébastien Viel, Magali Perret, et al.Neurology(R) Neuroimmunology & Neuroinflammation|February 22, 2023
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple SclerosisAlexandra Garcia, Emilie Dugast, Sita Shah, et al.Genes|December 24, 2021
Phenoconversion from Spastic Paraplegia to ALS/FTD Associated with CYP7B1 Compound Heterozygous MutationsJulian Theuriet, Antoine Pegat, Pascal Leblanc, et al.Annals of Neurology|July 7, 2017
Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathyNicolas Fissolo, Béatrice Pignolet, Clara Matute-Blanch, et al.Pageof 34